Investment type
Equity - Shares of Stock
Class
Common Stock, par value $0.0001 per share
Latest Disclosed Ownership
1.75M shares
Security Ownership
5.2%

Novo Holdings A/S ownership in ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share

2025-02-14 - Novo Holdings A/S has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.75M shares of ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share. This represents 5.2% percent ownership of the company.